ZNF75A
geneOn this page
Also known as FLJ31529
Summary
ZNF75A (zinc finger protein 75A, HGNC:13146) is a protein-coding gene on chromosome 16p13.3, encoding Zinc finger protein 75A (Q96N20). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7627 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 38 total
- MANE Select transcript:
NM_001302109
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13146 |
| Approved symbol | ZNF75A |
| Name | zinc finger protein 75A |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31529 |
| Ensembl gene | ENSG00000162086 |
| Ensembl biotype | protein_coding |
| OMIM | 601473 |
| Entrez | 7627 |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 10 protein_coding, 3 protein_coding_CDS_not_defined, 3 retained_intron, 1 nonsense_mediated_decay
ENST00000498240, ENST00000571101, ENST00000572999, ENST00000573828, ENST00000574298, ENST00000575234, ENST00000575253, ENST00000575812, ENST00000612186, ENST00000617839, ENST00000669516, ENST00000903407, ENST00000903408, ENST00000903409, ENST00000938989, ENST00000938990, ENST00000941569
RefSeq mRNA: 7 — MANE Select: NM_001302109
NM_001302109, NM_001324041, NM_001324085, NM_001352495, NM_001352497, NM_001352498, NM_153028
CCDS: CCDS10501, CCDS92095
Canonical transcript exons
ENST00000669516 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001817586 | 3308313 | 3308836 |
| ENSE00003643326 | 3316912 | 3317022 |
| ENSE00003854209 | 3313049 | 3313175 |
| ENSE00003864997 | 3317190 | 3318851 |
| ENSE00003869060 | 3311753 | 3311948 |
| ENSE00003877833 | 3312677 | 3312768 |
| ENSE00003899913 | 3305497 | 3305643 |
Expression profiles
Bgee: expression breadth ubiquitous, 251 present calls, max score 97.09.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.7596 / max 125.5259, expressed in 1754 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152420 | 14.7596 | 1754 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 97.09 | gold quality |
| kidney epithelium | UBERON:0004819 | 95.01 | silver quality |
| upper arm skin | UBERON:0004263 | 93.33 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 92.48 | silver quality |
| cardia of stomach | UBERON:0001162 | 92.18 | gold quality |
| buccal mucosa cell | CL:0002336 | 92.13 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 91.64 | gold quality |
| ganglionic eminence | UBERON:0004023 | 91.53 | gold quality |
| fallopian tube | UBERON:0003889 | 91.29 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 91.28 | gold quality |
| thyroid gland | UBERON:0002046 | 91.20 | gold quality |
| renal medulla | UBERON:0000362 | 91.07 | gold quality |
| nipple | UBERON:0002030 | 90.75 | gold quality |
| corpus callosum | UBERON:0002336 | 90.71 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.46 | gold quality |
| cerebellar cortex | UBERON:0002129 | 90.45 | gold quality |
| ventricular zone | UBERON:0003053 | 90.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.36 | gold quality |
| lymph node | UBERON:0000029 | 90.35 | gold quality |
| cortical plate | UBERON:0005343 | 90.33 | gold quality |
| cerebellum | UBERON:0002037 | 90.23 | gold quality |
| calcaneal tendon | UBERON:0003701 | 90.07 | gold quality |
| pylorus | UBERON:0001166 | 90.03 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 90.02 | gold quality |
| myocardium | UBERON:0002349 | 90.00 | silver quality |
| ventral tegmental area | UBERON:0002691 | 89.97 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 89.90 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.89 | gold quality |
| sural nerve | UBERON:0015488 | 89.74 | gold quality |
| pituitary gland | UBERON:0000007 | 89.73 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.36 |
| E-CURD-135 | no | 833.23 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2097.1 | ZNF75A | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:29638227
miRNA regulators (miRDB)
31 targeting ZNF75A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-4679 | 99.76 | 69.19 | 1229 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-5004-5P | 99.68 | 66.63 | 1294 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-1224-5P | 99.48 | 65.59 | 803 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-6882-5P | 99.35 | 71.13 | 1206 |
| HSA-MIR-185-5P | 99.35 | 68.60 | 2497 |
| HSA-MIR-4644 | 99.35 | 69.12 | 2514 |
| HSA-MIR-4652-3P | 99.33 | 70.02 | 2742 |
| HSA-MIR-8070 | 99.07 | 69.30 | 1303 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-3938 | 98.72 | 66.07 | 834 |
| HSA-MIR-124-5P | 98.11 | 67.65 | 1095 |
| HSA-MIR-219B-5P | 97.91 | 65.80 | 531 |
| HSA-MIR-3672 | 94.46 | 65.67 | 646 |
Cross-species orthologs
0 orthologs
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger protein 75A — Q96N20 (reviewed: Q96N20)
All UniProt accessions (4): A0A590UJ20, A0A590UJE0, Q96N20, Q86V93
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (7): NP_001289038, NP_001310970, NP_001311014, NP_001339424, NP_001339426, NP_001339427, NP_694573 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352
UniProt features (9 total): zinc finger region 5, sequence variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96N20-F1 | 74.43 | 0.45 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 45 (showing top):
RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BAHD1_TARGET_GENES, PTPRA_TARGET_GENES, SNAPC4_TARGET_GENES, ZNF610_TARGET_GENES, MIR4698, MIR4495, MIR302E, MIR3692_3P, MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P, MIR520A_3P, MIR372_3P, MIR520D_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
356 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF75A | TIGD7 | Q6NT04 | 606 |
| ZNF75A | C14orf180 | Q8N912 | 556 |
| ZNF75A | OR1F1 | O43749 | 418 |
| ZNF75A | ZNF395 | Q9H8N7 | 406 |
| ZNF75A | GARIN3 | Q8TC56 | 400 |
| ZNF75A | CTTNBP2NL | Q9P2B4 | 383 |
| ZNF75A | FLRT2 | O43155 | 371 |
| ZNF75A | ZNF654 | Q8IZM8 | 354 |
| ZNF75A | NTNG1 | Q9Y2I2 | 339 |
| ZNF75A | LHX4 | Q969G2 | 329 |
| ZNF75A | NKAPL | Q5M9Q1 | 313 |
| ZNF75A | PTRH2 | Q9Y3E5 | 310 |
| ZNF75A | ABCA12 | Q86UK0 | 307 |
| ZNF75A | NICN1 | Q9BSH3 | 306 |
| ZNF75A | SP140L | Q9H930 | 304 |
| ZNF75A | CHURC1 | Q8WUH1 | 304 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPANXN2 | ZNF75A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF71 | NVL | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF75A | TPP2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (10): ZNF75A (Affinity Capture-MS), SPANXN2 (Two-hybrid), HDAC6 (Affinity Capture-MS), TPP2 (Affinity Capture-MS), C1QTNF1 (Affinity Capture-MS), ZNF75A (Affinity Capture-MS), FOCAD (Affinity Capture-MS), PACSIN2 (Affinity Capture-MS), ZNF75A (Affinity Capture-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A2A761, A2T7D2, A3KN32, A3KN36, A7MBI1, B2RXC5, E9PYI1, O43296, P0CG31, P10072, P10078, P17023, P17097, P18725, P18728, P52738, Q02525, Q07231, Q0VCB0, Q12901, Q14592, Q49AA0, Q4V8A8, Q571J5, Q5CZA5, Q5JNZ3, Q5R7I8, Q5RB33, Q5RBX0, Q5RBY9, Q61967, Q62396, Q6PF04, Q6ZNG0, Q6ZS27, Q7Z398, Q80YP6, Q8BIQ3, Q8IZ26, Q96N20
Diamond homologs: A1L1L7, A3KN32, A3KN36, A6NFI3, A6NM28, A6NN14, A6QLU5, A7MBI1, A8K8V0, A8MTY0, A8MWA4, B4DU55, C9JBD0, G3X9G7, O60765, O75290, O94892, O95780, P0C7X2, P10072, P15622, P16373, P16374, P17023, P17032, P17097, P17098, P21506, P52742, P59923, Q06730, Q08DG8, Q16587, Q29RZ4, Q2TL60, Q3V080, Q49AA0, Q4R6C2, Q4V8A8, Q5FWF6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
38 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1601 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3311944:GAGGG:G | donor_gain | 1.0000 |
| 16:3312672:CACA:C | acceptor_loss | 1.0000 |
| 16:3312674:CAGCT:C | acceptor_loss | 1.0000 |
| 16:3312675:A:AG | acceptor_gain | 1.0000 |
| 16:3312675:AGCTG:A | acceptor_loss | 1.0000 |
| 16:3312676:G:GA | acceptor_gain | 1.0000 |
| 16:3312676:GCT:G | acceptor_gain | 1.0000 |
| 16:3312764:CCCAG:C | donor_loss | 1.0000 |
| 16:3312768:GGTG:G | donor_loss | 1.0000 |
| 16:3312769:G:A | donor_loss | 1.0000 |
| 16:3312770:T:G | donor_loss | 1.0000 |
| 16:3313047:A:AG | acceptor_gain | 1.0000 |
| 16:3313048:G:GG | acceptor_gain | 1.0000 |
| 16:3313048:GA:G | acceptor_gain | 1.0000 |
| 16:3305481:T:TA | donor_gain | 0.9900 |
| 16:3305626:G:GT | donor_gain | 0.9900 |
| 16:3305709:G:GT | donor_gain | 0.9900 |
| 16:3305710:G:T | donor_gain | 0.9900 |
| 16:3306057:G:GT | donor_gain | 0.9900 |
| 16:3308311:A:AG | acceptor_gain | 0.9900 |
| 16:3308312:G:GG | acceptor_gain | 0.9900 |
| 16:3311748:TCTA:T | acceptor_loss | 0.9900 |
| 16:3311751:A:AC | acceptor_loss | 0.9900 |
| 16:3311911:G:GT | donor_gain | 0.9900 |
| 16:3311946:GGG:G | donor_gain | 0.9900 |
| 16:3311947:GG:G | donor_gain | 0.9900 |
| 16:3311947:GGG:G | donor_gain | 0.9900 |
| 16:3311948:GG:G | donor_gain | 0.9900 |
| 16:3312674:C:G | acceptor_gain | 0.9900 |
| 16:3312675:AGCT:A | acceptor_gain | 0.9900 |
AlphaMissense
3575 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3317570:T:C | F198L | 0.999 |
| 16:3317572:T:A | F198L | 0.999 |
| 16:3317572:T:G | F198L | 0.999 |
| 16:3317654:T:C | F226L | 0.999 |
| 16:3317656:C:A | F226L | 0.999 |
| 16:3317656:C:G | F226L | 0.999 |
| 16:3317738:T:C | F254L | 0.999 |
| 16:3317740:C:A | F254L | 0.999 |
| 16:3317740:C:G | F254L | 0.999 |
| 16:3317695:T:A | H239Q | 0.998 |
| 16:3317695:T:G | H239Q | 0.998 |
| 16:3317589:T:C | L204P | 0.997 |
| 16:3317711:T:C | F245L | 0.997 |
| 16:3317713:C:A | F245L | 0.997 |
| 16:3317713:C:G | F245L | 0.997 |
| 16:3317757:T:C | L260P | 0.997 |
| 16:3317683:C:A | H235Q | 0.996 |
| 16:3317683:C:G | H235Q | 0.996 |
| 16:3317486:T:C | F170L | 0.995 |
| 16:3317488:C:A | F170L | 0.995 |
| 16:3317488:C:G | F170L | 0.995 |
| 16:3317571:T:C | F198S | 0.995 |
| 16:3317655:T:C | F226S | 0.995 |
| 16:3317681:C:G | H235D | 0.995 |
| 16:3317767:C:A | H263Q | 0.995 |
| 16:3317767:C:G | H263Q | 0.995 |
| 16:3317779:C:A | H267Q | 0.995 |
| 16:3317779:C:G | H267Q | 0.995 |
| 16:3317822:T:C | F282L | 0.995 |
| 16:3317824:C:A | F282L | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000239965 (16:3317432 A>G), RS1000286048 (16:3308477 A>C,G), RS1000289238 (16:3303924 C>G), RS1000295054 (16:3312568 G>A), RS1000734700 (16:3322157 T>A,C), RS1000842669 (16:3317841 T>G), RS1000907183 (16:3317718 G>A,T), RS1001000870 (16:3312771 G>A), RS1001048991 (16:3305394 G>A,T), RS1001143115 (16:3305180 C>T), RS1001176199 (16:3312269 G>C), RS1001207295 (16:3312508 C>T), RS1001281880 (16:3304413 C>G), RS1001386352 (16:3309414 C>A,T), RS1001526640 (16:3321795 G>A)
Disease associations
OMIM: gene MIM:601473 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004735_12 | Epstein-Barr virus copy number in lymphoblastoid cell lines | 2.000000e-07 |
| GCST006979_1054 | Heel bone mineral density | 4.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Valproic Acid | affects expression, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| ferrous chloride | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Air Pollutants | increases abundance, affects expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Quercetin | increases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Epstein-Barr virus infection